Drawing for CAELUS PHARMACEUTICALS

USPTO serial 79399417

CAELUS PHARMACEUTICALS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BACZESKI, LILLIANNA M
Law office
TMO LAW OFFICE 131

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CAELUS PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological services, and also assorted development and design; medical and pharmacological research services; development of pharmaceutical preparations, including vaccines and medicines; development of pharmaceutical products, carrying out evaluation of pharmaceutical products, conducting testing of pharmaceutical products, research in the field of pharmaceutical products, including medicines and vaccines; research in the field of pharmaceutical products, medicines and vaccines; laboratory research services related to pharmaceutical products, including medicines and vaccines; research and development in the field of new pharmaceutical products, including medicines and vaccines; research and development in the field of new products, food supplements and supplements, food for medical use; research and development in the field of new food supplements for human consumption; scientific research in the field of pharmacy; scientific research in the field of food and food supplements for the human body.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 14, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 13, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 10, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 10, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 9, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 9, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 8, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 8, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 18, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 3, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 3, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 13, 2025MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 13, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 4, 2025RFNTREFUSAL PROCESSED BY IB—
Feb 20, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 20, 2025RFRRREFUSAL PROCESSED BY MPU—
Jan 9, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 8, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2024DOCKASSIGNED TO EXAMINER—
Jul 12, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 12, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 8, 2024LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 5, 2024SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance